Page-2 of COVID-19 vaccine

Bharat Biotech Nasal Booster Trials

The Drug controller General of India has approved the COVAXIN booster trials. These boosters were produced by Bharat Biotech, the same company that produces COVAXIN. The boosters are being introduced for the vulnerable population. The booster doses will provide the ..

Month: 

Category: 

Three – dose ZyCov – D to be launched in seven states

ZyCov – D is the second indigenous vaccine next to COVAXIN. The unique feature of ZyCov – D is that it is needle – less vaccine. At first, the ZyCov – D vaccine is to be launched in seven states. ..

Month: 

‘Knock every door’ campaign for Second-dose Vaccination

Union Health Ministry has asked states and Union Territories to come up with district-level plan and launch a “Har Ghar Dastak” (Knock every door) campaign across poor performing districts. Key Facts Central government has also asked states & union territories ..

Month: 

India applies for vaccine loans from ADB & AIIB

India applied for a $2 billion loan from Asian Development Bank (ADB) and Asian Infrastructure Investment Bank (AIIB) to purchase about 700 million Covid-19 vaccines. Highlights India applied for the loan as it seeks to boost immunisation rate of eligible ..

Month: 

WHO seeks clarifications from Bharat Biotech on Covaxin

According to World Health Organisation (WHO), additional clarifications from manufacturer are required to conduct final Emergency Use Listing (EUL) risk-benefit assessment for using Bharat Biotech’s Covaxin globally. Key Points Technical advisory group are now scheduled to meet on November 3 ..

Month: 

Sri Lanka seeks $100-mn IMF loan to procure Covid Vaccine

Sri Lanka is seeking for a $100 million loan from the International Monetary Fund (IMF) in order to procure 14 million doses of the Pfizer Covid-19 vaccine. Highlights With this loan, Sri Lanka would also finance other vaccination programme related ..

Month: